HOME >> MEDICINE >> NEWS
Zevalin safe and effective for non-Hogdkin's lymphoma patients with advanced disease

ORLANDO, May 17 According to a University of Pittsburgh Medical Center (UPMC) study, patients with advanced non-Hodgkin's lymphoma (NHL) previously treated with chemotherapy and adult stem cell transplantation can safely tolerate ZevalinTM (ibritumomab tiuxetan), a radiolabeled monoclonal antibody that targets radiation directly to a tumor. The study, presented at the 41st annual meeting of the American Society of Clinical Oncology (ASCO) in Orlando, indicates that NHL patients who have received prior therapies for their disease respond safely to treatment with Zevalin.

A monoclonal antibody linked to the radioisotope, yttrium-90, Zevalin targets the CD20 antigen on the surface of mature B cells and B-cell tumors, and was approved in 2002 for the treatment of relapsed or refractory B-cell NHL. With Zevalin, radiation is added to the antibody to target the cancerous cells to the effects of ionizing irradiation. A major potential benefit to Zevalin is that treatment takes approximately eight days compared to six months of standard therapy.

"Patients with non-Hodgkin's lymphoma who have failed standard chemotherapy and have received stem cell transplantation have few treatment options available," said Samuel Jacobs, M.D., lead investigator and associate director for clinical investigations at the University of Pittsburgh Cancer Institute and UPMC Cancer Centers. "As a result, it is crucial to evaluate novel therapies in the advanced disease setting. Our preliminary results indicate that Zevalin is a safe option for these patients."

In the study, 11 patients who had received at least three prior therapy regimens including high-dose chemotherapy with adult stem cell transplantation were treated with Zevalin. Responses to the treatment were assessed pre- and post-treatment with PET/CT scans. According to results, three patients responded two with partial responses and one with a complete response lasting 11 months. Another patient rema
'"/>


17-May-2005


Page: 1 2

Related medicine news :

1. New treatment effective in counteracting cocaine-induced symptoms
2. Osteoporosis screening and treatment may be cost-effective for selected older men
3. Study shows radiofrequency ablation highly effective in treating kidney tumors
4. New study examines effectiveness of tailored health messages
5. Scaling up HIV prevention programs is cost effective
6. New study shows Rescue Remedy is an effective all-natural stress, anxiety reliever
7. U of M researchers assess effectiveness of computerized physician order entry system
8. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
9. Meningitis: effectiveness of preventive vaccination demonstrated
10. U-M study finds lymphoma drug effective over long term
11. Chemotherapy may enhance the effectiveness of brain tumor vaccines

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/14/2020)... ... February 14, 2020 , ... Cloudticity announced today ... the company’s support for healthcare organizations using Amazon Web Services (AWS). , “Our ... or experience to do so,” explained Cloudticity Founder & CEO, Gerry Miller. “In ...
(Date:2/13/2020)... (PRWEB) , ... February 13, 2020 , ... ... seven locations in Northern Virginia: Arlington, Dulles-Aldie, Fair Oaks, Fairfax, Fredericksburg, Leesburg, and ... that eight D.C.- and Virginia-based fertility specialists have been named as Top Docs ...
(Date:2/11/2020)... ... 2020 , ... Soterius, Inc., a global provider of cutting-edge ... new, significantly larger business premises in Lawrenceville, NJ. The move supports the requirements ... digital technology platforms. , “As our customer base and offerings continue to grow, ...
(Date:2/10/2020)... ... , ... A January 26 article on Live Science reports on ... that – not unlike the skin’s response to dangerous conditions like extreme heat or ... to potential damage being done and warn the individual to escape the situation. Pasadena-based ...
(Date:2/10/2020)... Md. (PRWEB) , ... February 10, 2020 , ... ... the Public Health and Epidemiology Practice, has been elected president of the ... Group where she and her team develop and implement award-winning, research-driven Federal social ...
Breaking Medicine News(10 mins):
(Date:2/15/2020)... ... February 14, 2020 , ... The creators of Dullo Plus - ... relaxing sleep experience—are excited to announce the launch of a Kickstarter campaign for 35 ... types of pillows over the last four years. Dullo Plus is their most advanced ...
(Date:2/14/2020)... (PRWEB) , ... February 14, 2020 , ... ... donation of $55,496 to Children’s Healthcare of Atlanta (Children’s) raised through their annual ... a portion of all new or pre-owned vehicle sales between November 29, 2019, ...
(Date:2/13/2020)... Va. (PRWEB) , ... February 13, 2020 , ... The ... is up 2.9% from the estimated value of $93.9 billion in 2010, according to ... market. , “Growth in this market is driven by an aging ...
Breaking Medicine Technology:
Cached News: